首页 > 最新文献

Hellenic journal of nuclear medicine最新文献

英文 中文
Extrastriatal uptake related to dopaminergic dysfunction on 99mTc-TRODAT-1 brain SPECT in patient with atypical meningioma. 非典型脑膜瘤患者在 99mTc-TRODAT-1 脑 SPECT 上出现与多巴胺能功能障碍有关的脑外摄取。
IF 1.5 4区 医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-09-01 Epub Date: 2023-12-14 DOI: 10.1967/s002449912606
Po-Nien Hou, Yu-Erh Huang, Shan-Ho Chan

Extrastriatal accumulation on technetium-99m-([2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]oct-2-yl]methyl](2-mercaptoethyl)amino]ethyl]amino]- ethanethiolato(3-)-N2,N2',S2,S2']oxo-[1R-(exo-exo)])(99mTc)-TRODAT-1 is unexpected during nuclear medicine nigrostriatal pathway examinations on 99mTc-TRODAT-1 brain single photon emission computed tomography (SPECT). An 86-year-old female with a history of right hemiparesis, speech expressive difficulties, unstable gait, and bradykinesia on right side was reported. Technetium-99m -TRODAT-1 dopamine transporter SPECT revealed an incidental extrastriatal accumulation of radiotracer in the left anterior frontal region, accompanied by a photopenic area which resulted in the displacement of the left striatum with decreased dopaminergic neuronal function. The brain magnetic resonance imaging (MRI) revealed an invasive meningioma corresponding to the extrastriatal uptake on SPECT, accompanied by edema and mass effect. The patient received surgery and the histopathological results confirmed the diagnosis of atypical meningioma.This study emphasizes the importance of understanding the underlying causes of extrastriatal uptake from 99mTc-TRODAT-1 brain SPECT, which may indicate an invasive brain tumor.

锝-99m-([2-[[2-[[[3-(4-氯苯基)-8-甲基-8-氮杂双环[3,2,1]辛-2-基]甲基](2-巯基乙胺)乙基]氨基]-乙硫醇(3-)-N2,N2',S2、S2']氧代-[1R-(外-外)])(99mTc)-TRODAT-1 在 99mTc-TRODAT-1 脑单光子发射计算机断层扫描(SPECT)的核医学黑质通路检查中出现意外。据报道,一名 86 岁的女性患者有右侧偏瘫、语言表达困难、步态不稳和右侧运动迟缓的病史。锝-99m-TRODAT-1多巴胺转运体SPECT检查发现,放射性示踪剂在左侧额叶前部偶然出现了椎体外积聚,并伴有光感区,导致左侧纹状体移位,多巴胺能神经元功能下降。脑磁共振成像(MRI)显示,患者患有侵袭性脑膜瘤,与SPECT显示的脑外摄取相吻合,并伴有水肿和肿块效应。这项研究强调了了解 99mTc-TRODAT-1 脑 SPECT 长轴外摄取的根本原因的重要性,因为这可能预示着侵袭性脑肿瘤。
{"title":"Extrastriatal uptake related to dopaminergic dysfunction on <sup>99m</sup>Tc-TRODAT-1 brain SPECT in patient with atypical meningioma.","authors":"Po-Nien Hou, Yu-Erh Huang, Shan-Ho Chan","doi":"10.1967/s002449912606","DOIUrl":"10.1967/s002449912606","url":null,"abstract":"<p><p>Extrastriatal accumulation on technetium-99m-([2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]oct-2-yl]methyl](2-mercaptoethyl)amino]ethyl]amino]- ethanethiolato(3-)-N2,N2',S2,S2']oxo-[1R-(exo-exo)])(<sup>99m</sup>Tc)-TRODAT-1 is unexpected during nuclear medicine nigrostriatal pathway examinations on <sup>99m</sup>Tc-TRODAT-1 brain single photon emission computed tomography (SPECT). An 86-year-old female with a history of right hemiparesis, speech expressive difficulties, unstable gait, and bradykinesia on right side was reported. Technetium-99m -TRODAT-1 dopamine transporter SPECT revealed an incidental extrastriatal accumulation of radiotracer in the left anterior frontal region, accompanied by a photopenic area which resulted in the displacement of the left striatum with decreased dopaminergic neuronal function. The brain magnetic resonance imaging (MRI) revealed an invasive meningioma corresponding to the extrastriatal uptake on SPECT, accompanied by edema and mass effect. The patient received surgery and the histopathological results confirmed the diagnosis of atypical meningioma.This study emphasizes the importance of understanding the underlying causes of extrastriatal uptake from <sup>99m</sup>Tc-TRODAT-1 brain SPECT, which may indicate an invasive brain tumor.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":" ","pages":"210-214"},"PeriodicalIF":1.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138802906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sources of error in direct radionuclide cystography in children and the need for a standardized, manometric apparatus. 儿童直接放射性核素膀胱造影术的误差来源以及对标准化压力测量仪器的需求。
IF 1.5 4区 医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-09-01 Epub Date: 2023-12-14 DOI: 10.1967/s002449912607
Christodoulos Likartsis, Nikoleta Taxtatzi, Athanasios Notopoulos, Argiris Doumas, Konstantinos Kollios, Nikoleta Printza

Direct radionuclide cystography (DRC) is a safe and reliable method for the detection and follow-up of vesico-ureteral reflux (VUR). Since the first DRC was performed, during the early 60s, the method has undergone many refinements. Themanometric approach, which was first introduced in 1984, provides a correlation between the bladder pressure and VUR visualization. In this study the sources of error that may alter the results of DRC are discussed and a novel, standardized low costmanometric apparatus is suggested.

直接放射性核素膀胱造影术(DRC)是一种安全可靠的膀胱输尿管反流(VUR)检测和随访方法。自上世纪 60 年代初首次进行直接放射性核素膀胱造影以来,该方法经历了多次改进。1984 年首次引入的人工计量法提供了膀胱压力和 VUR 可视化之间的相关性。本研究讨论了可能改变 DRC 结果的误差来源,并提出了一种新型、标准化、低成本的人工计量仪器。
{"title":"Sources of error in direct radionuclide cystography in children and the need for a standardized, manometric apparatus.","authors":"Christodoulos Likartsis, Nikoleta Taxtatzi, Athanasios Notopoulos, Argiris Doumas, Konstantinos Kollios, Nikoleta Printza","doi":"10.1967/s002449912607","DOIUrl":"10.1967/s002449912607","url":null,"abstract":"<p><p>Direct radionuclide cystography (DRC) is a safe and reliable method for the detection and follow-up of vesico-ureteral reflux (VUR). Since the first DRC was performed, during the early 60<sup>s</sup>, the method has undergone many refinements. Themanometric approach, which was first introduced in 1984, provides a correlation between the bladder pressure and VUR visualization. In this study the sources of error that may alter the results of DRC are discussed and a novel, standardized low costmanometric apparatus is suggested.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":" ","pages":"219-223"},"PeriodicalIF":1.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138803049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
May 18F-FAPI PET/CT differentiate Sutures granuloma from metastasis? A case report. 18F-FAPI PET/CT 可以区分脓疱性肉芽肿和转移瘤吗?病例报告。
IF 1.5 4区 医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-09-01 Epub Date: 2023-12-14 DOI: 10.1967/s002449912609
Jian He, Pan Li, Shuang Zhang

A 35-year-old woman received a surgery of sigmoid colon highly differentiated mucosal adenocarcinoma with greater omentum and peritoneum metastasis.The follow-up contrast-enhanced computed tomography (CT) revealed a new enhanced nodule on the transverse mesocolon about 6 months after surgery. Fluorine-18-fluorodeoxyglucose (18F-FDG) and 18F-fibroblast activation protein inhibitor (FAPI) positron emission tomography (PET)/CT were both performed to evaluate the potential lesions systematically, PET/CT images showed low 18F-FDG activity but very little 18F-FAPI activity in the nodule on the transverse mesocolon. Ultimately, the nodule was pathologically proved to be sutures granuloma. Maybe 18F-FAPI PET/CT is a potential choice to differentiate suture granulomas from metastasis.

一名35岁的女性接受了乙状结肠高分化粘膜腺癌伴大网膜和腹膜转移的手术。PET/CT 图像显示,结肠横系膜上的结节中 18F-FDG 活性较低,但 18F-FAPI 活性很低。最终,病理证实该结节为缝线肉芽肿。也许 18F-FAPI PET/CT 是区分缝合肉芽肿和转移瘤的潜在选择。
{"title":"May <sup>18</sup>F-FAPI PET/CT differentiate Sutures granuloma from metastasis? A case report.","authors":"Jian He, Pan Li, Shuang Zhang","doi":"10.1967/s002449912609","DOIUrl":"10.1967/s002449912609","url":null,"abstract":"<p><p>A 35-year-old woman received a surgery of sigmoid colon highly differentiated mucosal adenocarcinoma with greater omentum and peritoneum metastasis.The follow-up contrast-enhanced computed tomography (CT) revealed a new enhanced nodule on the transverse mesocolon about 6 months after surgery. Fluorine-18-fluorodeoxyglucose (<sup>18</sup>F-FDG) and <sup>18</sup>F-fibroblast activation protein inhibitor (FAPI) positron emission tomography (PET)/CT were both performed to evaluate the potential lesions systematically, PET/CT images showed low <sup>18</sup>F-FDG activity but very little <sup>18</sup>F-FAPI activity in the nodule on the transverse mesocolon. Ultimately, the nodule was pathologically proved to be sutures granuloma. Maybe <sup>18</sup>F-FAPI PET/CT is a potential choice to differentiate suture granulomas from metastasis.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":" ","pages":"226-227"},"PeriodicalIF":1.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138802922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners. 希腊核心脏病学会批准的核医学从业人员关于 ATTR 心脏淀粉样变性患者无创诊断的立场声明。
IF 1.5 4区 医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-09-01 Epub Date: 2023-12-14 DOI: 10.1967/s002449912600
M Koutelou, V Prassopoulos, L Lamprakos, A Zissimopoulos, T Chatzipanagiotou, A Mastorakou, A Doumas

Cardiac amyloidosis is a rare condition characterized by the accumulation of abnormal proteins called amyloids in the heart tissue. These amyloids can disrupt the normal functioning of the heart and lead to a variety of symptoms and complications.

心脏淀粉样变性是一种罕见的疾病,其特征是心脏组织中积聚称为淀粉样蛋白的异常蛋白质。这些淀粉样蛋白会破坏心脏的正常功能,导致各种症状和并发症。
{"title":"Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners.","authors":"M Koutelou, V Prassopoulos, L Lamprakos, A Zissimopoulos, T Chatzipanagiotou, A Mastorakou, A Doumas","doi":"10.1967/s002449912600","DOIUrl":"10.1967/s002449912600","url":null,"abstract":"<p><p>Cardiac amyloidosis is a rare condition characterized by the accumulation of abnormal proteins called amyloids in the heart tissue. These amyloids can disrupt the normal functioning of the heart and lead to a variety of symptoms and complications.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":" ","pages":"166-171"},"PeriodicalIF":1.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138802970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of bone SUV obtained from different SPECT/CT systems. 比较不同 SPECT/CT 系统获得的骨 SUV。
IF 1.5 4区 医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-09-01 Epub Date: 2023-12-14 DOI: 10.1967/s002449912602
Mana Yoshimura, Natsumi Kugai, Togo Aida, Daisuke Hakamata, Narii Miyajima, Yoshitake Takahashi

Objective: In bone scintigraphy, it is difficult to compare quantitative values, such as standardized uptake value (SUV), obtained from 2 different single-photon emission computed tomography combined with computed tomography (SPECT/CT) devices owing to differences of imaging acquisition and analysis methods. Therefore, the purpose of this study was to compare the SUV obtained from different SPECT/CT devices using the ratio to normal bone, and to analyze the correlation between them.

Subjects and methods: A total of 27 prostate cancer patients who underwent bone scintigraphy either using Symbia T16 or Symbia Intevo (Siemens Medical Solutions, Erlangen, Germany) were retrospectively analyzed. In each patient, spherical voxels of interest were placed on the following 5 reference points: humeral head (humerus), femoral neck (femur), lower part of the ilium (ilium), first lumbar vertebra (L1), fifth lumbar vertebra (L5), and the maximum SUV (SUVmax) and average SUV (SUVave) of these regions were measured.

Results: The mean and variance of SUVave (humerus) was the smallest on both SPECT/CT. To compare the SUV obtained from the 2 devices, the SUVave ratio and SUVmax ratio of each region were calculated as the SUVave and SUVmax of each region divided by the SUVave of the humeral head in each patient. Median values of the SUVmax ratio and SUVave ratio of each region showed similar tendencies in both devices, with correlation coefficients between 0.93 and 1.19.

Conclusion: Our results demonstrated that by expressing the quantitative value of SUVave of each region as a ratio to the SUVave of the humeral head, accumulation in the targeted bone can be compared even when the imaging acquisition and analysis methodsare different.

目的:在骨闪烁成像中,由于成像采集和分析方法的不同,很难比较两种不同的单光子发射计算机断层扫描结合计算机断层扫描(SPECT/CT)设备获得的定量值,如标准化摄取值(SUV)。因此,本研究的目的是利用与正常骨骼的比值来比较不同 SPECT/CT 设备获得的 SUV 值,并分析它们之间的相关性:回顾性分析了使用 Symbia T16 或 Symbia Intevo(西门子医疗解决方案公司,德国埃尔兰根)进行骨扫描的 27 位前列腺癌患者。在每位患者的肱骨头(肱骨)、股骨颈(股骨)、髂骨下部(髂骨)、第一腰椎(L1)、第五腰椎(L5)5 个参考点上放置感兴趣的球形体素,并测量这些区域的最大 SUV(SUVmax)和平均 SUV(SUVave):两种 SPECT/CT 的 SUVave(肱骨)平均值和方差均最小。为了比较两种设备获得的 SUV,计算了每个区域的 SUVave 比值和 SUVmax 比值,即每个区域的 SUVave 和 SUVmax 除以每位患者肱骨头的 SUVave。两种设备的各区域 SUVmax 比值和 SUVave 比值的中值显示出相似的趋势,相关系数介于 0.93 和 1.19 之间:我们的研究结果表明,通过将每个区域的 SUVave 定量值表示为与肱骨头 SUVave 的比值,即使成像采集和分析方法不同,也能比较靶骨的积聚情况。
{"title":"Comparison of bone SUV obtained from different SPECT/CT systems.","authors":"Mana Yoshimura, Natsumi Kugai, Togo Aida, Daisuke Hakamata, Narii Miyajima, Yoshitake Takahashi","doi":"10.1967/s002449912602","DOIUrl":"10.1967/s002449912602","url":null,"abstract":"<p><strong>Objective: </strong>In bone scintigraphy, it is difficult to compare quantitative values, such as standardized uptake value (SUV), obtained from 2 different single-photon emission computed tomography combined with computed tomography (SPECT/CT) devices owing to differences of imaging acquisition and analysis methods. Therefore, the purpose of this study was to compare the SUV obtained from different SPECT/CT devices using the ratio to normal bone, and to analyze the correlation between them.</p><p><strong>Subjects and methods: </strong>A total of 27 prostate cancer patients who underwent bone scintigraphy either using Symbia T16 or Symbia Intevo (Siemens Medical Solutions, Erlangen, Germany) were retrospectively analyzed. In each patient, spherical voxels of interest were placed on the following 5 reference points: humeral head (humerus), femoral neck (femur), lower part of the ilium (ilium), first lumbar vertebra (L1), fifth lumbar vertebra (L5), and the maximum SUV (SUV<sub>max</sub>) and average SUV (SUV<sub>ave</sub>) of these regions were measured.</p><p><strong>Results: </strong>The mean and variance of SUV<sub>ave</sub> (humerus) was the smallest on both SPECT/CT. To compare the SUV obtained from the 2 devices, the SUV<sub>ave</sub> ratio and SUV<sub>max</sub> ratio of each region were calculated as the SUV<sub>ave</sub> and SUV<sub>max</sub> of each region divided by the SUV<sub>ave</sub> of the humeral head in each patient. Median values of the SUV<sub>max</sub> ratio and SUV<sub>ave</sub> ratio of each region showed similar tendencies in both devices, with correlation coefficients between 0.93 and 1.19.</p><p><strong>Conclusion: </strong>Our results demonstrated that by expressing the quantitative value of SUV<sub>ave</sub> of each region as a ratio to the SUV<sub>ave</sub> of the humeral head, accumulation in the targeted bone can be compared even when the imaging acquisition and analysis methodsare different.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":" ","pages":"181-186"},"PeriodicalIF":1.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138802897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Vitamin D3 levels and dietary management in patients with papillary thyroid cancer. 评估甲状腺乳头状癌患者的维生素 D3 水平和饮食管理。
IF 1.5 4区 医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-09-01 Epub Date: 2023-12-14 DOI: 10.1967/s002449912604
Ana Vojislav Koljević-Marković, Danijela Kosta Ristić-Medić

Objective: Vitamin D (VitD) plays various roles, promotes musculoskeletal health, maintains parathyroid hormone levels and supports the immune processes. Vitamin D deficiency is common among cancer patients including thyroid cancer. Since some data indicate that preoperative VitD levels in cancer patients correlate with the further prognosis of the disease. Therefore, it is worthwhile to investigate this in the most common cancer of the thyroid gland, papillary thyroid cancer (PTC). The aim of this study was to evaluate serum VitD levels in patients with PTC concerning age, gender, body mass index (BMI), cancer stage, thyroid hormone levels, thyroglobulin concentration and the efficiency of VitD3 supplementation in these patients.

Subjects and methods: Our cross-sectional study included 105 patients, and 34 healthy subjects in the control group. After 12 weeks of VitD3 supplementation (insufficient patients received1000IJ/day, deficient patients 2000IJ/day, severe deficient patient 5000IJ/day) along with the lifestyle and dietary management, the response was evaluated according to the personal characteristics, levels of VitD, free thyroxine (FT4), freetriiodothyronine (FT3) hormones and thyroglobulin (TG).

Results: The responders whose median age was 61-year-old, were mostly women (94%), with BMI below 23.7kg/m3, which indicates that most of the patients were normally nourished. 70% of patients were in the first stage of PTC, 76% had a vitamin D deficiency, while musculoskeletal disorders were present in 30% patients. VitD supplementation improved serum VitD status, FT3 discretely elevated and the TG levels significantly decreased in our PTC patients.

Conclusion: It should be noted that VitD deficiency is presented in 70% of patients with PTC in our study sample. Dietary recommendation applied as lifestyle changes along with oral VitD3 supplementation, corrected VitD status to the recommended serum level. Although the data from our study is not sufficient to evaluate the VitD level as a prognostic factor for cancer, we have shown that it is necessary to examine its level along with an individual dietary approach for each patient with PTC.

目的维生素 D(VitD)具有多种作用,可促进肌肉骨骼健康、维持甲状旁腺激素水平和支持免疫过程。包括甲状腺癌在内的癌症患者普遍缺乏维生素 D。有数据表明,癌症患者术前的维生素 D 水平与疾病的进一步预后相关。因此,值得对甲状腺最常见的癌症--甲状腺乳头状癌(PTC)进行研究。本研究旨在评估PTC患者的血清VitD水平,涉及这些患者的年龄、性别、体重指数(BMI)、癌症分期、甲状腺激素水平、甲状腺球蛋白浓度以及补充VitD3的效果:我们的横断面研究包括 105 名患者和 34 名健康对照组受试者。在补充 VitD3 12 周后(不足患者每天补充 1000IJ,缺乏患者每天补充 2000IJ,严重缺乏患者每天补充 5000IJ),同时进行生活方式和饮食管理,根据个人特征、VitD 水平、游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3)激素和甲状腺球蛋白(TG)对反应进行评估:应答者的中位年龄为 61 岁,大部分为女性(94%),体重指数低于 23.7kg/m3,这表明大部分患者营养状况正常。70% 的患者处于 PTC 第一阶段,76% 的患者缺乏维生素 D,30% 的患者存在肌肉骨骼疾病。补充维生素 D 改善了 PTC 患者的血清维生素 D 状态,FT3 明显升高,TG 水平显著下降:应当指出的是,在我们的研究样本中,70% 的 PTC 患者存在维生素 D 缺乏症。改变生活方式的饮食建议以及口服维生素 D3 补充剂可将维生素 D 状态纠正到推荐的血清水平。虽然我们的研究数据还不足以将维生素 D 水平作为癌症的预后因素进行评估,但我们已经证明,有必要在检查维生素 D 水平的同时,为每位 PTC 患者制定个性化的饮食方案。
{"title":"Evaluation of Vitamin D3 levels and dietary management in patients with papillary thyroid cancer.","authors":"Ana Vojislav Koljević-Marković, Danijela Kosta Ristić-Medić","doi":"10.1967/s002449912604","DOIUrl":"10.1967/s002449912604","url":null,"abstract":"<p><strong>Objective: </strong>Vitamin D (VitD) plays various roles, promotes musculoskeletal health, maintains parathyroid hormone levels and supports the immune processes. Vitamin D deficiency is common among cancer patients including thyroid cancer. Since some data indicate that preoperative VitD levels in cancer patients correlate with the further prognosis of the disease. Therefore, it is worthwhile to investigate this in the most common cancer of the thyroid gland, papillary thyroid cancer (PTC). The aim of this study was to evaluate serum VitD levels in patients with PTC concerning age, gender, body mass index (BMI), cancer stage, thyroid hormone levels, thyroglobulin concentration and the efficiency of VitD3 supplementation in these patients.</p><p><strong>Subjects and methods: </strong>Our cross-sectional study included 105 patients, and 34 healthy subjects in the control group. After 12 weeks of VitD3 supplementation (insufficient patients received1000IJ/day, deficient patients 2000IJ/day, severe deficient patient 5000IJ/day) along with the lifestyle and dietary management, the response was evaluated according to the personal characteristics, levels of VitD, free thyroxine (FT4), freetriiodothyronine (FT3) hormones and thyroglobulin (TG).</p><p><strong>Results: </strong>The responders whose median age was 61-year-old, were mostly women (94%), with BMI below 23.7kg/m<sup>3</sup>, which indicates that most of the patients were normally nourished. 70% of patients were in the first stage of PTC, 76% had a vitamin D deficiency, while musculoskeletal disorders were present in 30% patients. VitD supplementation improved serum VitD status, FT3 discretely elevated and the TG levels significantly decreased in our PTC patients.</p><p><strong>Conclusion: </strong>It should be noted that VitD deficiency is presented in 70% of patients with PTC in our study sample. Dietary recommendation applied as lifestyle changes along with oral VitD3 supplementation, corrected VitD status to the recommended serum level. Although the data from our study is not sufficient to evaluate the VitD level as a prognostic factor for cancer, we have shown that it is necessary to examine its level along with an individual dietary approach for each patient with PTC.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":" ","pages":"194-200"},"PeriodicalIF":1.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138802899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of 18F-FDG PET/CT in the detection of eosinophilic esophagitis. 18F-FDG PET/CT 在检测嗜酸性粒细胞食管炎中的作用。
IF 1.5 4区 医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-09-01 Epub Date: 2023-12-14 DOI: 10.1967/s002449912605
Jie Zhou, Ming Zhao, Jing Wang, Rongrong Tian, Ming Zhao

Eosinophilic esophagitis (EoE) is a rare immune-mediated chronic inflammatory disease of the esophagus. The main symptoms are dysphagia, retrosternal pain, and repeated food impaction. Esophageal eosinophilic infiltration is seen on histopathological examination. Progressive esophageal stenosis and other complications may occur if not detected and treated. We report a patient with pathologically confirmed EoE whose disease was detected on fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT). This case demonstrates the important role of 18F-FDG PET/CT in the diagnosis of eosinophilic esophagitis.

嗜酸性粒细胞食管炎(EoE)是一种罕见的免疫介导的食管慢性炎症性疾病。主要症状是吞咽困难、胸骨后疼痛和反复食物嵌塞。组织病理学检查可见食管嗜酸性粒细胞浸润。如果不及时发现和治疗,可能会出现进行性食管狭窄和其他并发症。我们报告了一名经病理确诊的食管炎患者,该患者的疾病是通过氟-18-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(18F-FDG PET/CT)发现的。该病例证明了 18F-FDG PET/CT 在诊断嗜酸性粒细胞食管炎中的重要作用。
{"title":"Role of <sup>18</sup>F-FDG PET/CT in the detection of eosinophilic esophagitis.","authors":"Jie Zhou, Ming Zhao, Jing Wang, Rongrong Tian, Ming Zhao","doi":"10.1967/s002449912605","DOIUrl":"10.1967/s002449912605","url":null,"abstract":"<p><p>Eosinophilic esophagitis (EoE) is a rare immune-mediated chronic inflammatory disease of the esophagus. The main symptoms are dysphagia, retrosternal pain, and repeated food impaction. Esophageal eosinophilic infiltration is seen on histopathological examination. Progressive esophageal stenosis and other complications may occur if not detected and treated. We report a patient with pathologically confirmed EoE whose disease was detected on fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG PET/CT). This case demonstrates the important role of <sup>18</sup>F-FDG PET/CT in the diagnosis of eosinophilic esophagitis.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":" ","pages":"207-209"},"PeriodicalIF":1.5,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138803040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of pediatric papillary thyroid cancer. 癌症的治疗。
IF 1.5 4区 医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-05-01
Kalliopi Pazaitou-Panayiotou

Papillary thyroid carcinoma (PTC) originates from the follicular cell of the thyroid gland. PTC is a rare cancer and usually develops in pre-existing thyroid nodules, which are not common in children. PTC is often multifocal and bilateral. Low-risk subtypes such as classic PTC and follicular variant account for the majority of PTC, while high-risk histologic subtypes such as tall cell variant, diffuse sclerosing variant and poorly differentiated thyroid cancer occur more rarely in children. It is worth noting that the size of the thyroid in children is smaller compared to that of adults. Therefore, the size criteria used for tumor staging as well as the diagnosis of papillary microcarcinoma in adults, do not apply to children. Family history of thyroid cancer, exposure to external radiation, iodine deficiency, and autoimmune thyroid diseases as well as some genetic syndromes increase the risk of its occurrence.

乳头状甲状腺癌(PTC)起源于甲状腺的滤泡细胞。PTC是一种罕见的癌症,通常发生在预先存在的甲状腺结节中,这在儿童中并不常见。PTC通常是多灶性和双侧的。低风险亚型,如经典PTC和毛囊变异,占PTC的大多数,而高风险组织学亚型,例如高细胞变异、弥漫性硬化变异和低分化甲状腺癌症,在儿童中更罕见。值得注意的是,与成人相比,儿童甲状腺的大小较小。因此,用于成人乳头状微癌的肿瘤分期和诊断的大小标准不适用于儿童。甲状腺癌症家族史、暴露于外部辐射、碘缺乏、自身免疫性甲状腺疾病以及一些遗传综合征增加了其发生的风险。
{"title":"Management of pediatric papillary thyroid cancer.","authors":"Kalliopi Pazaitou-Panayiotou","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Papillary thyroid carcinoma (PTC) originates from the follicular cell of the thyroid gland. PTC is a rare cancer and usually develops in pre-existing thyroid nodules, which are not common in children. PTC is often multifocal and bilateral. Low-risk subtypes such as classic PTC and follicular variant account for the majority of PTC, while high-risk histologic subtypes such as tall cell variant, diffuse sclerosing variant and poorly differentiated thyroid cancer occur more rarely in children. It is worth noting that the size of the thyroid in children is smaller compared to that of adults. Therefore, the size criteria used for tumor staging as well as the diagnosis of papillary microcarcinoma in adults, do not apply to children. Family history of thyroid cancer, exposure to external radiation, iodine deficiency, and autoimmune thyroid diseases as well as some genetic syndromes increase the risk of its occurrence.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":"26 Suppl ","pages":"60-64"},"PeriodicalIF":1.5,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10129169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive diagnostic approach to cardiac events in cancer patients receiving antineoplastic therapy: A systematic review. 接受抗肿瘤治疗的癌症患者心脏事件的综合诊断方法:系统综述。
IF 1.5 4区 医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-05-01
C Lafaras, I Kalafatis, K Lafara, V Koukoulitsa, E Mandala

Oncologic patients are vulnerable to a broad spectrum of cancer related cardiovascular complications during and/or after antineoplastic treatment. This article is dealing with the main drugs used in real world clinical practice, including conventional chemotherapy, targeted therapy, immunotherapy, radiotherapy and their potential cardiovascular toxicity. Diagnosis of cancer- related cardiovascular events requires thorough clinical evaluation, multimodality imaging techniques and cardiac biomarkers according to established guidelines of cardio-oncology. Multidisciplinary approach and individualized strategies are essential and crucial in confronting oncologic patients.

肿瘤患者在抗肿瘤治疗期间和/或之后容易出现广泛的癌症相关心血管并发症。本文介绍了现实世界临床实践中使用的主要药物,包括常规化疗、靶向治疗、免疫治疗、放射治疗及其潜在的心血管毒性。癌症相关心血管事件的诊断需要根据既定的心脏病学指南进行全面的临床评估、多模态成像技术和心脏生物标志物。多学科方法和个体化策略在面对肿瘤学患者时至关重要。
{"title":"A comprehensive diagnostic approach to cardiac events in cancer patients receiving antineoplastic therapy: A systematic review.","authors":"C Lafaras,&nbsp;I Kalafatis,&nbsp;K Lafara,&nbsp;V Koukoulitsa,&nbsp;E Mandala","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Oncologic patients are vulnerable to a broad spectrum of cancer related cardiovascular complications during and/or after antineoplastic treatment. This article is dealing with the main drugs used in real world clinical practice, including conventional chemotherapy, targeted therapy, immunotherapy, radiotherapy and their potential cardiovascular toxicity. Diagnosis of cancer- related cardiovascular events requires thorough clinical evaluation, multimodality imaging techniques and cardiac biomarkers according to established guidelines of cardio-oncology. Multidisciplinary approach and individualized strategies are essential and crucial in confronting oncologic patients.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":"26 Suppl ","pages":"5-11"},"PeriodicalIF":1.5,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10141286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic value of 18F-FDG PET/CT and 68Ga-FAPI PET/CT in primary liver cancer: A systematic review and meta-analysis. 18F-FDG PET/CT和68Ga-FAPI PET/CT对原发性肝癌的诊断价值:系统综述和荟萃分析。
IF 1.5 4区 医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-05-01 Epub Date: 2023-08-04 DOI: 10.1967/s002449912575
Ma Jiao, Tang Mingsong, Jiang Hao, Zhang Chunyin

Objective: To conduct a meta-analysis of the diagnostic efficacy of fluorine-18-fluorodeoxyglucose (18F-FDG) and gallium-68-labeled fibroblast-activation protein inhibitor (68Ga-FAPI) positron emission tomography/computed tomography (PET/CT) for primary liver cancer based on existing clinical evidence.

Materials and methods: Meta-analysis was carried out according to PRISMA reporting specification. The clinical studies in PubMed/Medline, Embase and the Cochrane Library database were retrieved from the establishment to September 2022. Two researchers independently conducted literature screening and data extraction, evaluated the risk of bias according to QUADAS-2, conducted meta-analysis using Meta Disc 1.4 and Stata15.1 software, and calculated the summarized sensitivity (SEN), specificity (SPE), positive likelihood ratio (+LR), negative likelihood ratio (-LR), and diagnostic odds ratio (DOR). The diagnostic performance of 18F-FDG PET/CT and 68Ga-FAPI PET/CT for primary liver cancer was compared using summarized receiver operating characteristic (SROC) curve and area under curve (AUC).

Results: Four original studies on 18F-FDG PET/CT and 68Ga-FAPI PET/CT in the diagnosis of primary liver cancer were included, including 159 intrahepatic lesions in 106 patients. Taking lesions as a unit, in four original studies, the pooled results of 18F-FDG PET/CT diagnosis of primary liver cancer were Sen=0.5 (95% CI:95% CI: 0.41-0.59), Spe=0.87 (95% CI: 0.52-0.98), AUC=0.58 (95% CI:0.53-0.62); The pooled results of 68Ga-FAPI PET/CT in the diagnosis of primary liver cancer, Sen=0.5 (95% CI: 0.41-0.59), Spe=0.87 (95%CI:0.52-0.98), AUC=0.58 (95% CI:0.53-0.62). Besides, the Sen of 68Ga-FAPI PET/CT in the diagnosis of primary liver cancer was higher than that of 18F-FDG PET/CT (Z=2.323, P=0.02), the difference was statistically significant.

Conclusion: Gallium-68-FAPI PET/CT is a promising tool. Compared with 18F-FDG, 68Ga-FAPI has higher sensitivity to detect more lesions in primary liver cancer and metastatic lesions, and has high performance in the diagnosis of primary liver cancer.

目的:根据现有临床证据,对氟18-氟脱氧葡萄糖(18F-FDG)和镓68-标记的成纤维细胞活化蛋白抑制剂(68Ga-FAPI)正电子发射断层扫描/计算机断层扫描(PET/CT)对原发性癌症的诊断效果进行荟萃分析。材料和方法:根据PRISMA报告规范进行荟萃分析。PubMed/Medline、Embase和Cochrane图书馆数据库中的临床研究是从建立到2022年9月检索的。两名研究人员独立进行文献筛选和数据提取,根据QUADAS-2评估偏倚风险,使用meta Disc 1.4和Stata15.1软件进行荟萃分析,并计算总结敏感性(SEN)、特异性(SPE)、阳性似然比(+LR)、阴性似然比(-LR)和诊断优势比(DOR)。应用总结受试者工作特征曲线(SROC)和曲线下面积(AUC)比较18F-FDG PET/CT和68Ga-FAPI PET/CT对原发性肝癌的诊断效果。结果:纳入4项18F-FDG PET/CT和68Ga-FAPI PET/CT在原发性肝癌诊断中的原始研究,包括106例患者的159个肝内病变。以病变为单位,在4项原始研究中,18F-FDG PET/CT诊断原发性肝癌癌症的合并结果分别为Sen=0.5(95%CI:95%CI:0.41~0.59)、Spe=0.87(95%CI:0.52~0.98)、AUC=0.58(95%CI=0.53~0.62);68Ga-FAPI PET/CT诊断原发性肝癌的合并结果Sen=0.5(95%CI:0.41~0.59),Spe=0.87(95%CI:0.52~0.98),AUC=0.58(95%CI:0.53~0.62),68Ga-FAPIPET/CT在原发性癌症诊断中的Sen高于18F-FDG PET/CT(Z=2.323,P=0.02),差异有统计学意义。结论:镓68-FAPI PET/CT是一种很有前途的成像工具。与18F-FDG相比,68Ga-FAPI在原发性肝癌癌症和转移病灶中检测更多病灶的灵敏度更高,在诊断原发性癌症方面具有较高的表现。
{"title":"Diagnostic value of <sup>18</sup>F-FDG PET/CT and <sup>68</sup>Ga-FAPI PET/CT in primary liver cancer: A systematic review and meta-analysis.","authors":"Ma Jiao,&nbsp;Tang Mingsong,&nbsp;Jiang Hao,&nbsp;Zhang Chunyin","doi":"10.1967/s002449912575","DOIUrl":"10.1967/s002449912575","url":null,"abstract":"<p><strong>Objective: </strong>To conduct a meta-analysis of the diagnostic efficacy of fluorine-18-fluorodeoxyglucose (<sup>18</sup>F-FDG) and gallium-68-labeled fibroblast-activation protein inhibitor (<sup>68</sup>Ga-FAPI) positron emission tomography/computed tomography (PET/CT) for primary liver cancer based on existing clinical evidence.</p><p><strong>Materials and methods: </strong>Meta-analysis was carried out according to PRISMA reporting specification. The clinical studies in PubMed/Medline, Embase and the Cochrane Library database were retrieved from the establishment to September 2022. Two researchers independently conducted literature screening and data extraction, evaluated the risk of bias according to QUADAS-2, conducted meta-analysis using Meta Disc 1.4 and Stata15.1 software, and calculated the summarized sensitivity (SEN), specificity (SPE), positive likelihood ratio (+LR), negative likelihood ratio (-LR), and diagnostic odds ratio (DOR). The diagnostic performance of <sup>18</sup>F-FDG PET/CT and <sup>68</sup>Ga-FAPI PET/CT for primary liver cancer was compared using summarized receiver operating characteristic (SROC) curve and area under curve (AUC).</p><p><strong>Results: </strong>Four original studies on <sup>18</sup>F-FDG PET/CT and <sup>68</sup>Ga-FAPI PET/CT in the diagnosis of primary liver cancer were included, including 159 intrahepatic lesions in 106 patients. Taking lesions as a unit, in four original studies, the pooled results of <sup>18</sup>F-FDG PET/CT diagnosis of primary liver cancer were Sen=0.5 (95% CI:95% CI: 0.41-0.59), Spe=0.87 (95% CI: 0.52-0.98), AUC=0.58 (95% CI:0.53-0.62); The pooled results of <sup>68</sup>Ga-FAPI PET/CT in the diagnosis of primary liver cancer, Sen=0.5 (95% CI: 0.41-0.59), Spe=0.87 (95%CI:0.52-0.98), AUC=0.58 (95% CI:0.53-0.62). Besides, the Sen of <sup>68</sup>Ga-FAPI PET/CT in the diagnosis of primary liver cancer was higher than that of <sup>18</sup>F-FDG PET/CT (Z=2.323, P=0.02), the difference was statistically significant.</p><p><strong>Conclusion: </strong>Gallium-68-FAPI PET/CT is a promising tool. Compared with <sup>18</sup>F-FDG, <sup>68</sup>Ga-FAPI has higher sensitivity to detect more lesions in primary liver cancer and metastatic lesions, and has high performance in the diagnosis of primary liver cancer.</p>","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":"26 2","pages":"123-131"},"PeriodicalIF":1.5,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10045773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hellenic journal of nuclear medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1